Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check3 days agoChange DetectedAccess to the study page now shows a 403 Forbidden error, replacing the study content with a standard error page header and footer; the visible content indicates the page is blocked rather than displaying the record details.SummaryDifference18%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new Revision: v3.6.6 was added and the previous Revision: v3.6.5 was removed, reflecting an update to the page's version metadata.SummaryDifference0.1%

- Check45 days agoChange DetectedThe revision label in the page footer was updated from v3.6.4 to v3.6.5, signaling an updated build of the page without altering study details or navigation.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a small backend or content management system update rather than a change to the study information or visible layout.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This is a minor metadata update to the study record rather than a substantive change to the content.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update reflects a minor maintenance or content update without altering the study details presented.SummaryDifference0.1%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.